Table.

 Demographic and Clinical Characteristics of Study Population

	Total	Candesartan	Placebo	P
Age	58±10	55±8	60±12	NS
Male	27 (96%)	13 (93%)	14 (100%)	NS
Smoke	25 (89%)	13 (93%)	12 (86%)	NS
Alcohol	7 (25%)	3 (21%)	4 (29%)	NS
Months from diagnosis of hypertension	69±50	62±55	75±44	NS
β‐Blockers
Atenolol	15 (54%)	5 (36%)	10 (71%)	NS
Carvedilol	3 (11%)	3 (21%)	0 (0%)
Metoprolol	10 (35%)	6 (43%)	4 (29%)
Blood pressure
Systolic (mm Hg)	123±13	119±9	126±15	NS
Diastolic (mm Hg)	78±8	79±9	78±7	NS
FMD	4.8±0.8	4.6±0.9	5.0±0.7	NS

Abbreviations: NS, not significant; FMD, flow‐mediated dilation.